Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Cleave Therapeutics Inc., Worldwide Clinical Trials
Scientific Title
A Phase 1 Study to Evaluate the Safety and Pharmacokinetic Profiles of CB-5339 in Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed/Refractory Intermediate or High Risk Myelodysplastic Syndrome